| Authors: |
Kishimoto T; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA; Department of Psychiatry and Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA. Electronic address: tkishimoto@keio.jp., Hagi K; Sumitomo Dainippon Pharma, Tokyo, Japan., Kurokawa S; Department of Neuropsychiatry, Keio University School of Medicine, Tokyo 160-8582, Japan., Kane JM; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA; Department of Psychiatry and Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA., Correll CU; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, New York, NY, USA; Department of Psychiatry and Department of Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA; The Feinstein Institute for Medical Research, Center for Psychiatric Neuroscience, Manhasset, NY, USA; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin, Berlin, Germany. |
